⌘K

Login Start Free

Arcadia Biosciences, Inc.·4/A

Aug 28, 1:01 PM ET

Plavan Matthew T 4/A

4/A · Arcadia Biosciences, Inc. · Filed Aug 28, 2019

Insider Transaction Report

Form 4/AAmended

Period: 2019-08-26

Arcadia Biosciences, Inc.RKDA

Plavan Matthew T

Chief Financial Officer

Transactions

Purchase
Common Stock
2019-08-27$8.93/sh+2,000$17,860→ 7,000 total
Purchase
Common Stock
2019-08-26$8.33/sh+1,000$8,330→ 1,000 total
Purchase
Common Stock
2019-08-26$9.22/sh+1,000$9,220→ 2,000 total
Purchase
Common Stock
2019-08-27$9.30/sh+1,000$9,300→ 4,000 total
Purchase
Common Stock
2019-08-27$9.32/sh+1,000$9,320→ 3,000 total
Purchase
Common Stock
2019-08-27$8.95/sh+1,000$8,950→ 5,000 total
Purchase
Common Stock
2019-08-28$6.88/sh+1,000$6,880→ 8,000 total

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION